74 related articles for article (PubMed ID: 22816789)
1. Molecular characterization of central neurocytomas: potential markers for tumor typing and progression.
Vasiljevic A; Champier J; Figarella-Branger D; Wierinckx A; Jouvet A; Fèvre-Montange M
Neuropathology; 2013 Apr; 33(2):149-61. PubMed ID: 22816789
[TBL] [Abstract][Full Text] [Related]
2. Central neurocytomas express photoreceptor differentiation.
Mena H; Morrison AL; Jones RV; Gyure KA
Cancer; 2001 Jan; 91(1):136-43. PubMed ID: 11148570
[TBL] [Abstract][Full Text] [Related]
3. Expression of N-myc downstream regulated gene 1 (NDRG1) in central neurocytoma.
Fotovati A; Abu-Ali S; Sugita Y; Nakamura Y
J Clin Neurosci; 2011 Oct; 18(10):1383-5. PubMed ID: 21784644
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis reveals differential gene expression patterns in tumors of the pineal region.
Fèvre-Montange M; Champier J; Szathmari A; Wierinckx A; Mottolese C; Guyotat J; Figarella-Branger D; Jouvet A; Lachuer J
J Neuropathol Exp Neurol; 2006 Jul; 65(7):675-84. PubMed ID: 16825954
[TBL] [Abstract][Full Text] [Related]
5. Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance.
Korshunov A; Sycheva R; Golanov A
Acta Neuropathol; 2007 Mar; 113(3):303-12. PubMed ID: 17123091
[TBL] [Abstract][Full Text] [Related]
6. Frontal transcortical approach in 12 central neurocytomas.
Park ES; Cho YH; Kim JH; Kim SJ; Khang SK; Kim CJ
Acta Neurochir (Wien); 2012 Nov; 154(11):1961-71; discussion 1972. PubMed ID: 22948746
[TBL] [Abstract][Full Text] [Related]
7. Histopathological variants of central neurocytoma: Report of 10 cases.
Favereaux A; Vital A; Loiseau H; Dousset V; Caille J; Petry K
Ann Pathol; 2000 Dec; 20(6):558-63. PubMed ID: 11148351
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
[TBL] [Abstract][Full Text] [Related]
9. The natural history of a recurrent central neurocytoma-like tumor.
Wharton SB; Antoun NM; Macfarlane R; Anderson JR
Clin Neuropathol; 1998; 17(3):136-40. PubMed ID: 9625305
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of intraventricular central neurocytomas and extraventricular neurocytomas.
Xiong Z; Zhang J; Li Z; Jiang J; Han Q; Sun S; Wu X; Wang Y; Lei T; Chen J
J Neurooncol; 2015 Feb; 121(3):521-9. PubMed ID: 25385573
[TBL] [Abstract][Full Text] [Related]
11. Histogenesis and differentiation potential of central neurocytomas.
von Deimling A; Kleihues P; Saremaslani P; Yasargil MG; Spoerri O; Südhof TC; Wiestler OD
Lab Invest; 1991 Apr; 64(4):585-91. PubMed ID: 1901927
[TBL] [Abstract][Full Text] [Related]
12. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
13. The evolution of the anaplastic cerebellar liponeurocytoma: case report and review of the literature.
Radke J; Gehlhaar C; Lenze D; Capper D; Bock A; Heppner FL; Jödicke A; Koch A
Clin Neuropathol; 2015; 34(1):19-25. PubMed ID: 25250652
[TBL] [Abstract][Full Text] [Related]
14. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
[TBL] [Abstract][Full Text] [Related]
15. Recurrent central neurocytoma with marked increase in MIB-1 labelling index.
Christov C; Adle-Biassette H; Le Guerinel C
Br J Neurosurg; 1999 Oct; 13(5):496-9. PubMed ID: 10627783
[TBL] [Abstract][Full Text] [Related]
16. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?
Underwood M; Bartlett J; Reeves J; Gardiner DS; Scott R; Cooke T
Cancer Res; 1995 Jun; 55(11):2422-30. PubMed ID: 7757996
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in central neurocytomas: a multicenter study of 71 cases.
Vasiljevic A; François P; Loundou A; Fèvre-Montange M; Jouvet A; Roche PH; Figarella-Branger D
Am J Surg Pathol; 2012 Feb; 36(2):220-7. PubMed ID: 22251941
[TBL] [Abstract][Full Text] [Related]
18. Recurrent central neurocytomas.
Bertalanffy A; Roessler K; Koperek O; Gelpi E; Prayer D; Knosp E
Cancer; 2005 Jul; 104(1):135-42. PubMed ID: 15880432
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.
Kim EJ; Lee YS; Kim YJ; Kim MJ; Ha YS; Jeong P; Lee OJ; Kim WJ
Urology; 2010 Jun; 75(6):1516.e9-13. PubMed ID: 19913893
[TBL] [Abstract][Full Text] [Related]
20. Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma.
Soylemezoglu F; Onder S; Tezel GG; Berker M
Pathol Res Pract; 2003; 199(7):463-8. PubMed ID: 14521262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
